SureSelect XT HS2 DNA Reagent Kit
Agilent TechnologiesThe SureSelect XT HS2 DNA Reagent Kit is Agilent’s most cutting-edge library prep and target enrichment solution for Illumina sequencing
The SureSelect XT HS2 DNA Reagent Kit is Agilent’s most cutting-edge library prep and target enrichment solution for Illumina sequencing
Join us on Thursday, December 10, to discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research
Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research
Learn about the future of newborn screening in this guest editorial from Clinical and Laboratory Standards Institute
Hear how researchers have discovered a new cellular mechanism that controls the stability of messenger RNA (mRNA) in cells
Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency
Researchers identify SDR42E1 as a critical regulator of vitamin D metabolism, revealing its potential as a dual-purpose target for precision therapies
Collaboration follows successful acquisition and commercialization of Oxsed, an Oxford University Spin-out, to scale OxLAMP rapid COVID-19 test globally
Join us on Thursday, December 17, to learn ways to improve time to result in critical pathways such as sepsis
250 µl, pre-stained, Strep-tagged recombinant proteins (10–250 kD), including three pink reference bands (25, 50, 75 kD), 50 applications
Discover how a team of researchers have utilized machine learning to unlock the secrets held in the core of the Earth
How is globalization impacting the transmission of infectious diseases and what response is required from global health networks for greater security?